Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2.2% | +112.4% | 3 / 3 | +5.6% | +3.51 pp | +2.58 pp | +24.4% | 2.10 | 13.44 | 718 | +5,6% | 80,5 | +37,2% | 13.44 | 12.12 | +10,9% |
| Pts | 0 | 12 | 12 | 0 | 12 | 12 | 12 | -4 | 8 | |||||||
Valuation annotation:Price: 48.000 (close price on 2026-10-19)EPS (TTM): 3.571
Financial charts
1.Revenue & growth
VND bn718Q2/26
1.Revenue & growth
VND bn718Q2/26
2.Profit & growth
VND bn80,4Q2/26
3.Profit mix (Penman)
VND bn252Q2/26
4.Margins & cost structure
%25.3%Q2/26
5.Returns & cash cycle
% · days12.3%Q2/26
6.Earnings quality & cash
VND bn-105Q2/26
7.Asset structure
VND bn3.281Q2/26
8.Funding & debt health
VND bn · times3.281Q2/26
9.Revenue backlog
VND bn14,9Q2/26
10.Valuation
times · %13,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.313Q2/26
Adjusted EPS growth, latest quarter
20.0%
Average adjusted EPS growth, 3 quarters
145%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26